Prescription Required.Why?
A sulfonylurea oral antidiabetic drug that stimulates insulin release from the pancreas.
A biguanide oral antidiabetic drug that improves insulin sensitivity and reduces glucose production by the liver.
A fat-soluble vitamin essential for calcium absorption, bone health, and potentially impacting insulin sensitivity.
Type 2 diabetes mellitus (T2DM) in adults when metformin alone is insufficient to control blood glucose levels.
Specifically indicated for patients who require the combined action of a sulfonylurea, a biguanide, and supplemental Vitamin D3 to manage their blood sugar.
This combination medication works synergistically. Glimepiride stimulates insulin secretion from the pancreas, while metformin enhances insulin sensitivity and reduces hepatic glucose production. Vitamin D3's role in this combination is less clearly defined but may contribute to improved insulin sensitivity and potentially better glycemic control.
Store at room temperature (below 30°C) in a dry place, away from direct sunlight and moisture. Keep out of the reach of children.
Dosage should always be prescribed by a doctor and individualized based on patient needs and response.
Generally, the medication is taken orally, typically once daily with meals to reduce gastrointestinal side effects.
The dose may be gradually increased or decreased as directed by the physician based on blood sugar monitoring.
Gastrointestinal issues (nausea, vomiting, diarrhea) – more common with metformin.
Hypoglycemia (low blood sugar): Symptoms include dizziness, sweating, tremor, weakness, hunger.
Allergic reactions (rash, itching, swelling).
Weight gain (possible with glimepiride).
Elevated liver enzymes (rare).
Alcohol should be consumed in moderation or avoided entirely, as it can increase the risk of hypoglycemia and lactic acidosis.
If experiencing hypoglycemia, avoid driving or operating machinery. Dosage adjustments may be needed.
Generally, not recommended during pregnancy and breastfeeding. Consult a doctor immediately if pregnancy is planned or suspected.
Not usually indicated for children. Use in children is not established.
Metformin is contraindicated in patients with severe kidney disease. Dose adjustments are necessary in patients with mild to moderate renal impairment.
Caution is advised in patients with liver disease. Liver function monitoring might be necessary.
Consult your physician or pharmacist for specific references and detailed information on the specific formulation.
